Juxian Sun

992 total citations
45 papers, 546 citations indexed

About

Juxian Sun is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juxian Sun has authored 45 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hepatology, 26 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juxian Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and Cancer, Lipids, and Metabolism (8 papers). Juxian Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (31 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and Cancer, Lipids, and Metabolism (8 papers). Juxian Sun collaborates with scholars based in China, Hong Kong and United States. Juxian Sun's co-authors include Shuqun Cheng, Jie Shi, Wan Yee Lau, Wei‐Xing Guo, Mengchao Wu, Zong‐Tao Chai, Xiuping Zhang, Jianqiang Cai, Minshan Chen and Xinyu Bi and has published in prestigious journals such as Molecular Therapy, Signal Transduction and Targeted Therapy and Annals of Surgical Oncology.

In The Last Decade

Juxian Sun

35 papers receiving 540 citations

Peers

Juxian Sun
Feng Shen China
Yong‐Fa Zhang China
Erlei Zhang China
Tenyu Motoyama Japan
Yong Le China
Che-Chuan Loong Taiwan
Lianghe Lu China
MinShan Chen China
Yannan Bai China
Guoliang Shao China
Feng Shen China
Juxian Sun
Citations per year, relative to Juxian Sun Juxian Sun (= 1×) peers Feng Shen

Countries citing papers authored by Juxian Sun

Since Specialization
Citations

This map shows the geographic impact of Juxian Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juxian Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juxian Sun more than expected).

Fields of papers citing papers by Juxian Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juxian Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juxian Sun. The network helps show where Juxian Sun may publish in the future.

Co-authorship network of co-authors of Juxian Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Juxian Sun. A scholar is included among the top collaborators of Juxian Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juxian Sun. Juxian Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Juxian, Yong Xia, Feng Shen, & Shuqun Cheng. (2025). Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition). HepatoBiliary Surgery and Nutrition. 14(2). 246–266.
2.
Jiang, Yabo, Xubiao Wei, Bin Zhou, et al.. (2025). RAC1 directly phosphorylates both PKM2 and FBP1 to promote radioresistance in hepatocellular carcinoma. Molecular Therapy. 34(2). 1201–1214.
3.
4.
Wang, Xu, Yuqing Zhang, Liheng Liu, et al.. (2024). Prognostic and Immunotherapeutic Predictive Value of CAD Gene in Hepatocellular Carcinoma: Integrated Bioinformatics and Experimental Analysis. Molecular Biotechnology. 67(3). 1240–1255. 2 indexed citations
5.
6.
Sun, Juxian, Chang Liu, Fan Zhang, et al.. (2023). Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study. Signal Transduction and Targeted Therapy. 8(1). 368–368. 17 indexed citations
7.
8.
Wu, Xiaobing, et al.. (2022). A Double Suspension Technique for Laparoscopic Isolated Caudate Lobectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. 32(10). 1102–1107.
9.
10.
11.
Wu, Jiayi, Juxian Sun, Yannan Bai, et al.. (2021). Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 28(12). 7686–7695. 4 indexed citations
12.
Sun, Juxian, Jiayi Wu, Chang Liu, et al.. (2021). Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma. Cancer Biology and Medicine. 18(3). 808–815. 3 indexed citations
13.
Wu, Jiayi, Juxian Sun, Xiao‐Xiao Huang, et al.. (2021). Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 29(2). 949–958. 3 indexed citations
14.
15.
Sun, Juxian, Jiayi Wu, Jie Shi, et al.. (2020). Thrombus-First Surgery for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus. Journal of Gastrointestinal Surgery. 25(8). 1973–1979. 4 indexed citations
16.
Chen, Zhenhua, Xiuping Zhang, Hang Wang, et al.. (2019). Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis. HPB. 21(8). 935–944. 62 indexed citations
17.
Cheng, Shuqun, Minshan Chen, Jianqiang Cai, et al.. (2019). Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition). Liver Cancer. 9(1). 28–40. 114 indexed citations
18.
Zhang, Xiuping & Juxian Sun. (2017). Current situation of diagnosis and treatment for hepatocellular carcinoma complicated with bile duct tumor thrombi. 6(5). 343–346. 1 indexed citations
19.
Li, Nan, Jie Xue, Wei‐Xing Guo, et al.. (2015). Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest. Experimental and Therapeutic Medicine. 9(5). 1709–1718. 16 indexed citations
20.
Ding, Xinyu, et al.. (2014). Reconstruction of large-size abdominal wall defect using biodegradable poly-p-dioxanone mesh: an experimental canine study. World Journal of Surgical Oncology. 12(1). 57–57. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feng Shen Breakdown of academic impact, for papers by Yong‐Fa Zhang Breakdown of academic impact, for papers by Erlei Zhang Breakdown of academic impact, for papers by Tenyu Motoyama Breakdown of academic impact, for papers by Yong Le Breakdown of academic impact, for papers by Che-Chuan Loong Breakdown of academic impact, for papers by Lianghe Lu Breakdown of academic impact, for papers by MinShan Chen Breakdown of academic impact, for papers by Yannan Bai Breakdown of academic impact, for papers by Guoliang Shao
Rankless by CCL
2026